
    
      The purpose of this study is to determine whether the combination product, sumatriptan and
      naproxen sodium, is effective compared to placebo in the treatment of acute migraine in
      adolescent subjects 12-17 years old. Subjects will treat two migraine attacks over a ~25 week
      period.
    
  